Sara Reference Manual Chapter2
Sara Reference Manual Chapter2
Sara Reference Manual Chapter2
An annual monitoring
system for service delivery
Reference Manual
WHO/HIS/HSI/2014.5 Rev.1
All rights reserved. Publications of the World Health Organization are available on the WHO website
(www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211
Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]).
Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial
distribution– should be addressed to WHO Press through the WHO website
(www.who.int/about/licensing/copyright_form/en/index.html).
The designations employed and the presentation of the material in this publication do not imply the expression
of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any
country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full
agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that they are
endorsed or recommended by the World Health Organization in preference to others of a similar nature that
are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by
initial capital letters.
All reasonable precautions have been taken by the World Health Organization to verify the information
contained in this publication. However, the published material is being distributed without warranty of any
kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the
reader. In no event shall the World Health Organization be liable for damages arising from its use.
An annual monitoring
system for service delivery
Reference Manual
Version 2.2
Revised July 2015
Acknowledgements
The service availability and readiness assessment (SARA) methodology was developed through a joint World
Health Organization (WHO) – United States Agency for International Development (USAID) collaboration. The
methodology builds upon previous and current approaches designed to assess service delivery including the
service availability mapping (SAM) tool developed by WHO, and the service provision assessment (SPA) tool
developed by ICF International under the USAID-funded MEASURE DHS project (monitoring and evaluation to
assess and use results, demographic and health surveys) project, among others. It draws on best practices and
lessons learned from the many countries that have implemented health facility assessments as well as
guidelines and standards developed by WHO technical programmes and the work of the International Health
Facility Assessment Network (IHFAN).
Particular thanks are extended to all those who contributed to the development of the service readiness
indicators, indices, and questionnaires during the workshop on "Strengthening Monitoring of Health Services
Readiness" held in Geneva, 22–23 September 2010.
Many thanks to The Norwegian Agency for Development Cooperation (Norad) whom has supported Statistics
Norway to take part in the development of the SARA tools. The support has contributed to the development
and implementation of a new electronic questionnaire in CSPro and data verification guidelines.
A special thanks to the Medicines Information and Evidence for Policy unit at WHO for their contribution to the
SARA training materials and to the Unidad de Calidad y Seguridad de la Atención Médica-Hospital General de
México for their contribution of photographs to the SARA data collectors' guide.
2
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
Table of contents
Acknowledgements ...........................................................................................................2
Abbreviations ....................................................................................................................4
3
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
Abbreviations
AIDS acquired immunodeficiency syndrome
ALT alanine aminotransferase
CBR crude birth rate
CSV comma-separated values
DBS dried blood spot
DCMI Dublin Core Metadata Initiative
DDI Data Documentation Initiative
DQRC Data quality report card
DV Data verification
EDC electronic data collection device
FBO faith-based organization
GIS geographical information system
GPS global positioning system
HIV human immunodeficiency virus
HMIS health management information system
HRIS human resources information system
ID identification
IHFAN International Health Facility Assessment Network
IHP+ International Health Partnership and related initiatives
IHSN International Household Survey Network
M&E monitoring and evaluation
MDG Millennium Development Goal
MFL master facility list
MNCH maternal, newborn and child health
MoH ministry of health
NADA national data archive
NGO nongovernmental organization
OECD Organisation for Economic Co-operation and Development
PMTCT prevention of mother-to-child transmission (of HIV)
RDT rapid diagnostic test
SAM service availability mapping
SARA service availability and readiness assessment
SPA service provision assessment
UNAIDS Joint United Nations Programme on HIV/AIDS
UNDP United Nations Development Programme
UNICEF United Nations Children’s Fund
USAID United States Agency for International Development
WHO World Health Organization
XML extensible markup language
4
2. Core instrument
65
2. Core instrument
The SARA core instrument is a questionnaire broken down into the following sections:
− Interviewer visits
− Facility identification
− Geographic coordinates
− General information
• Section 2: Staffing
• Section 4: Infrastructure
− Communications
− Ambulance/transport for emergencies
− Power supply
− Basic client amenities
− Infection control
− Processing of equipment for reuse
− Health care waste management
− Supervision
− Basic equipment
− Infection control precautions
− Family planning
− Antenatal care
− Prevention of mother-to-child transmission of HIV
− Obstetric and newborn care
− Caesarean section
− Immunization
− Child preventative and curative care
− Adolescent health
− HIV counselling and testing
− HIV treatment
− HIV care and support
− Sexually transmitted infections
− Tuberculosis
− Malaria
− Non-communicable diseases
− Surgery
− Blood transfusion
• Section 6: Diagnostics
66
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
002 Is this a supervisor validation check of a DATA COLLECTION FOR FACILITY ASSESSMENT…………… 1
facility? SUPERVISOR VALIDATION .…………………………………………… 2
FINAL VISIT
1 2 3
FACILITY IDENTIFICATION
003 Name of facility
____________________________________
004 Location of facility
____________________________________
005 Region/Province
006 District
67
2. Core instrument
MOVE TO MAIN ENTRANCE OF THE BUILDING. STAND WITHIN 30 METERS OF DOOR WHERE ENTRANCE IS IN PLAIN
VIEW TO THE SKY.
1. TURN GPS RECEIVER ON AND WAIT UNTIL SATELLITE PAGE INDICATES "READY TO NAVIGATE" AND
ACCURACY IS AT A RECOMMANDED LEVEL
2. GO TO THE “MENU” PAGE AND SELECT "MARK"
3. HIGHLIGHT THE WAYPOINT NUMBER AND PRESS "ENTER"
4. ENTER FACILITY CODE AND PRESS “ENTER” TO GO BACK TO THE “MARK” PAGE
5. HIGHLIGHT "OK" AND PRESS "ENTER" TO REGISTER THE WAYPOINT
6. GO TO THE MENU PAGE, HIGHLIGHT "WAYPOINT" AND PRESS "ENTER"
7. HIGHLIGHT THE WAYPOINT AND PRESS “ENTER” TO OPEN ITS DETAILED INFORMATION
8. COPY INFORMATION FROM WAYPOINT LIST PAGE IN THE FORM BELOW
BE SURE TO COPY THE WAYPOINT NAME (FACILITY NUMBER) FROM THE WAYPOINT LIST PAGE TO VERIFY THAT
YOU ARE ENTERING THE CORRECT WAYPOINT INFORMATION ON THE DATA FORM
011 Waypoint name
(Facility number)
012 Altitude
Meters
013 Latitude
N/S……………… a
DEGREES/DEC b . c
014 Longitude
E/W……………… a
DEGREES/DEC b . c
68
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
FIND THE MANAGER, THE PERSON IN-CHARGE OF THE FACILITY, OR MOST SENIOR HEALTH WORKER RESPONSIBLE
FOR OUTPATIENT SERVICES WHO IS PRESENT AT THE FACILITY. READ THE FOLLOWING GREETING:
Good day! My name is _____________________. We are here on behalf of [IMPLEMENTING AGENCY] conducting
a survey of health facilities to assist the government in knowing more about health services in [COUNTRY].
Now I will read a statement explaining the study.
Your facility was selected to participate in this study. We will be asking you questions about various health
services. Information about your facility may be used by the [MOH], organizations supporting services in your
facility, and researchers, for planning service improvement or for conducting further studies of health services.
Neither your name nor that of any other health worker respondents participating in this study will be included in
the dataset or in any report; however, there is a small chance that any of these respondents may be identified
later. Still, we are asking for your help to ensure that the information we collect is accurate.
You may refuse to answer any question or choose to stop the interview at any time. However, we hope you will
answer the questions, which will benefit the services you provide and the nation.
If there are questions for which someone else is the most appropriate person to provide the information, we
would appreciate if you introduce us to that person to help us collect that information.
At this point, do you have any questions about the study? Do I have your agreement to proceed?
_________________________________________ 2 0 1
INTERVIEWER'S SIGNATURE INDICATING CONSENT OBTAINED DAY MONTH YEAR
015 May I begin the interview?
YES ..................................................... 1
NO ...................................................... 2 5001
016 INTERVIEW START TIME (use the 24 hour-clock :
system)
69
2. Core instrument
S4 03 Non-physician clinicians/paramedical
professionals
S4 04 Nursing professionals
S4 05 Midwifery professionals
08 Pharmacists
70
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
71
2. Core instrument
Q415
413 Is the generator functional?
YES ............................................................. 1
NO ............................................................. 2 415
DON’T KNOW .......................................... 98 415
72
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
Q417
73
2. Core instrument
INFECTION CONTROL
T1 422 Does this facility have any guidelines on
standard precautions for infection prevention? YES, OBSERVED.......................................... 1
IF YES, ASK TO SEE THE DOCUMENT YES, REPORTED NOT SEEN ........................ 2
NO ............................................................. 3
PROCESSING OF EQUIPMENTS FOR REUSE
423 Please tell me if the following items used for A) AVAILABLE B) FUNCTIONING
processing of equipment for reuse are available
and functional in the facility today.
REPORTED NOT DON’T
IF AVAILABLE, ASK TO SEE IT AND INDICATE IF IT IS OBSERVED YES NO
NOT SEEN AVAILABLE KNOW
FUNCTIONING OR NOT
74
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
Q430
75
2. Core instrument
76
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
77
2. Core instrument
78
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
79
2. Core instrument
ASK TO BE SHOWN THE LOCATION IN THE FACILITY WHERE ANTENATAL CARE SERVICES ARE PROVIDED. FIND THE
PERSON MOST KNOWLEDGEABLE ABOUT ANTENATAL CARE SERVICES IN THE FACILITY. INTRODUCE YOURSELF,
EXPLAIN THE PURPOSE OF THE SURVEY AND ASK THE FOLLOWING QUESTIONS.
801 Do ANC providers provide any of the
following services to pregnant women as part
of routine ANC services? YES NO
S8_01 01 Iron supplementation 1 2
S8_02 02 Folic acid supplementation 1 2
S8_03 03 Intermittent preventive treatment in
1 2
pregnancy (IPTp) for malaria
S8_04 04 Tetanus toxoid immunization 1 2
S8_05 05 Monitoring for hypertensive disorder of
1 2
pregnancy
802 Please tell me if the following documents are YES,
available in the facility today: YES, REPORTED
IF AVAILABLE, ASK TO SEE THE DOCUMENT OBSERVED NOT SEEN NO
T4 01 National ANC guidelines 1 2 3
T63 02 Any ANC check-lists and/or job-aids 1 2 3
T19 03 IPTp guidelines, check-lists and/or job-aids
(including wall charts) 1 2 3
ACCEPTABLE IF PART OF ANC GUIDELINES.
ASK TO BE SHOWN THE LOCATION IN THE FACILITY WHERE PMTCT SERVICES ARE PROVIDED. FIND THE PERSON
MOST KNOWLEDGEABLE ABOUT PMTCT SERVICES IN THE FACILITY. INTRODUCE YOURSELF, EXPLAIN THE PURPOSE
OF THE SURVEY AND ASK THE FOLLOWING QUESTIONS.
901 As part of PMTCT services, please tell me if
this facility provides the following services to
clients: YES NO
S20_01 01 Provide HIV counselling and testing services
1 2
to HIV positive pregnant women for PMTCT
S20_02 02 Provide HIV counselling and testing services
to infants born to HIV positive pregnant 1 2
women for PMTCT
S20_03 03 Provide ARV prophylaxis to HIV positive
1 2
pregnant women for PMTCT
80
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
81
2. Core instrument
82
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
83
2. Core instrument
84
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
Q1009
1008 Is the oxytocin stored in cold storage?
YES ............................................................. 1
NO ............................................................. 2
CESAREAN SECTION
1009 CHECK Q1002_08:
CESAREAN SECTION OFFERED CESAREAN SECTION NOT OFFERED
Q1100
T51 1010 Do you have the national guidelines for
Comprehensive Emergency Obstetric Care YES, OBSERVED.......................................... 1
(CEmOC) available in this facility today? YES, REPORTED NOT SEEN ........................ 2
IF AVAILABLE, ASK TO SEE THE DOCUMENT NO .............................................................3
85
2. Core instrument
86
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
87
2. Core instrument
E39 01 Thermometer 3
E47
1→B 2→B 1 2 8
02
E39 02 Continuous temperature recorder/logger 3
1→B 2→B 1 2 8
E47 1112
88
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
1115 CHECK Q1101 AND Q1108: FACILITY DOES NOT OFFER IMMUNIZATION
FACILITY IS OFFERING IMMUNIZATION SERVICES TODAY (Q1101 = “2”) AND DOES
SERVICES TODAY (Q1101 =“1” ) OR HAS A NOT HAVE A FUNCTIONAL REFRIGERATOR
FUNCTIONNING REFRIGERATOR FOR THE FOR THE STORAGE OF VACCINES (Q1108 =
STORAGE OF VACCINES (Q1108 = “1”) “2”, “3” OR “4”)
Q1117
89
2. Core instrument
ASK TO BE SHOWN THE LOCATION IN THE FACILITY WHERE CHILD PREVENTATIVE AND CURATIVE CARE SERVICES ARE
PROVIDED. FIND THE PERSON MOST KNOWLEDGEABLE ABOUT CHILD PREVENTATIVE AND CURATIVE CARE SERVICES
IN THE FACILITY. INTRODUCE YOURSELF, EXPLAIN THE PURPOSE OF THE SURVEY AND ASK THE FOLLOWING
QUESTIONS.
1201 Please tell me if this facility provides the
following services: YES NO
S11_01 01 Diagnose and/or treat child malnutrition 1 2
S11_02 02 Provide vitamin A supplementation 1 2
S11_03 03 Provide iron supplementation 1 2
S11_04 04 Provide ORS to children with diarrhoea 1 2
S11_04 05 Provide zinc supplementation to children with
1 2
diarrhoea
S11_05 06 Child growth monitoring 1 2
S11_06 07 Treatment of pneumonia 1 2
S11_07 08 Administration of amoxicillin for the
1 2
treatment of pneumonia in children
S11_08 09 Treatment of malaria in children
1 2
90
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
91
2. Core instrument
D6 1405 Does this facility have HIV rapid test kits (with
valid expiration date) in stock in this service YES, OBSERVED.......................................... 1
site today? YES, REPORTED NOT SEEN ........................ 2
CHECK TO SEE IF VALID (NOT EXPIRED) NO ............................................................. 3
M17 1406 Does this facility have condoms available in
M91 this service site today to give to clients YES, OBSERVED.......................................... 1
receiving services? YES, REPORTED NOT SEEN ........................ 2
IF YES, ASK TO SEE CONDOMS NO ............................................................. 3
1407 Please tell me if the following
resources/supplies used for infection control
are available in this service area today. REPORTED NOT
ASK TO SEE THE ITEMS OBSERVED NOT SEEN AVAILABLE
I15 01 Clean running water (piped, bucket with tap,
1 2 3
or pour pitcher)
I15 02 Hand-washing soap/liquid soap 1 2 3
I15 03 Alcohol based hand rub 1 2 3
I16 04 Disposable latex gloves 1 2 3
I12 05 Waste receptacle (pedal bin) with lid and
1 2 3
plastic bin liner
I11 06 Sharps container ("safety box") 1 2 3
I13 07 Environmental disinfectant (e.g., chlorine,
1 2 3
alcohol)
I14 08 Disposable syringes with disposable needles 1 2 3
I14 09 Auto-disable syringes 1 2 3
HIV TREATMENT
S19 1500 Does this facility offer HIV & AIDS
antiretroviral prescription or antiretroviral YES ............................................................. 1
treatment follow-up services? NO ............................................................. 2 1600
ASK TO BE SHOWN THE LOCATION IN THE FACILITY WHERE HIV TREATMENT SERVICES ARE PROVIDED. FIND THE
PERSON MOST KNOWLEDGEABLE ABOUT HIV TREATMENT SERVICES IN THE FACILITY. INTRODUCE YOURSELF,
EXPLAIN THE PURPOSE OF THE SURVEY AND ASK THE FOLLOWING QUESTIONS.
1501 Do providers in this facility:
YES NO
S19_01 01 Prescribe ART 1 2
S12_09 02 Prescribe ART to adolescents 1 2
S19_02 1502 Does this facility provide treatment follow-up
services for persons on ART, including YES ............................................................. 1
providing community-based services? NO ............................................................. 2
T35 1503 Do you have the national ART guidelines
available in this facility today? YES, OBSERVED.......................................... 1
IF AVAILABLE, ASK TO SEE THE DOCUMENT YES, REPORTED NOT SEEN ........................ 2
NO ............................................................. 3
92
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
93
2. Core instrument
TUBERCULOSIS
S16 1800 Does this facility offer diagnosis, treatment
prescription, or treatment follow-up of YES ............................................................. 1
tuberculosis? NO ............................................................. 2 1900
ASK TO BE SHOWN THE LOCATION IN THE FACILITY WHERE TUBERCULOSIS SERVICES ARE PROVIDED. FIND THE
PERSON MOST KNOWLEDGEABLE ABOUT TUBERCULOSIS SERVICES IN THE FACILITY. INTRODUCE YOURSELF,
EXPLAIN THE PURPOSE OF THE SURVEY AND ASK THE FOLLOWING QUESTIONS.
S16_01 1801 Do providers in this facility diagnose TB?
YES ............................................................. 1
NO ............................................................. 2 1803
94
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
S16_02 03 Culture
1 2
S16_05
95
2. Core instrument
M41 01 Ethambutol 1 2 3 4 5
M41 02 Isoniazid 1 2 3 4 5
M41 03 Pyrazinamide 1 2 3 4 5
M41 04 Rifampicin 1 2 3 4 5
M41 05 Isoniazid + Rifampicin (2FDC) 1 2 3 4 5
M41 06 Isoniazid + Ethambutol (EH) (2FDC) 1 2 3 4 5
M41 07 Isoniazid + Rifampicin + Pyrazinamide (RHZ)
1 2 3 4 5
(3FDC)
M41 08 Isoniazid + Rifampicin + Ethambutol (RHE)
1 2 3 4 5
(3FDC)
M41 09 Isoniazid + Rifampicin + Pyrazinamide +
1 2 3 4 5
Ethambutol (4FDC)
10 Streptomycin Injectable 1 2 3 4 5
MALARIA
S15 1900 Does this facility offer diagnosis or treatment
of malaria? YES ............................................................. 1
NO ............................................................. 2 2000
ASK TO BE SHOWN THE LOCATION IN THE FACILITY WHERE MALARIA SERVICES ARE PROVIDED. FIND THE
PERSON MOST KNOWLEDGEABLE ABOUT MALARIA SERVICES IN THE FACILITY. INTRODUCE YOURSELF, EXPLAIN
THE PURPOSE OF THE SURVEY AND ASK THE FOLLOWING QUESTIONS.
S15_01 1901 Do providers in this facility diagnose malaria?
YES ............................................................. 1
NO ............................................................. 2 1906
1902 Which of the following methods are used at
this facility for diagnosing malaria:
YES NO
S15_05 01 Clinical symptoms 1 2
S15_02 02 Rapid diagnostic testing (RDT)
1 2
S15_06
S15_02 03 Microscopy
S15_07
1 2
96
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
CHECK Q1902_02:
IF FACILITY CONDUCTS MALARIA RDTS: IF FACILITY DOES NOT CONDUCT
MALARIA RDTS: Q1906
97
2. Core instrument
98
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
E44 02 Speculum 3
1→B 2→B 2100 1 2 8
E. SURGERY
SURGICAL SERVICES
S25 2100 Does this facility offer any surgical services
S28 (including minor surgery such as suturing, YES ............................................................. 1
circumcision, wound debridement, etc.), or NO ............................................................. 2 2200
caesarean section?
ASK TO BE SHOWN THE LOCATION IN THE FACILITY WHERE SURGICAL SERVICES ARE PROVIDED. FIND THE PERSON
MOST KNOWLEDGEABLE ABOUT SURGICAL SERVICES IN THE FACILITY. INTRODUCE YOURSELF, EXPLAIN THE
PURPOSE OF THE SURVEY AND ASK THE FOLLOWING QUESTIONS.
2101 Please tell me if this facility provides the
following services: YES NO
S25_01 01 Incision and drainage of abscesses 1 2
S25_02 02 Wound debridement 1 2
S25_03 03 Acute burn management 1 2
S25_04 04 Suturing 1 2
S25_05 05 Closed repair of fracture 1 2
S25_06 06 Cricothyroidotomy 1 2
S25_07 07 Male circumcision 1 2
S25_08 08 Hydrocele reduction 1 2
S25_09 09 Chest tube insertion 1 2
S25_10 10 Closed repair of dislocated joint 1 2
S25_11 11 Biopsy of lymph node or mass or other 1 2
S25_12 12 Removal of foreign body (throat, eye, ear or
1 2
nose)
99
2. Core instrument
CHECK Q007:
IF HOSPITAL: IF NOT HOSPITAL:
Q2102
S28_01 13 Tracheostomy 1 2
S28_02 14 Tubal ligation 1 2
S28_03 15 Vasectomy 1 2
S28_04 16 Dilatation & Curettage 1 2
S28_05 17 Obstetric fistula repair 1 2
S28_06 18 Episiotomy, cervical and vaginal laceration 1 2
S28_07 19 Appendectomy 1 2
S28_08 20 Hernia repair (strangulated) 1 2
S28_22 21 Hernia repair (elective) 1 2
S28_09 22 Cystostomy 1 2
S28_10 23 Urethral stricture dilatation 1 2
S28_11 24 Laparotomy (uterine rupture, ectopic
pregnancy, acute abdomen, intestinal 1 2
obstruction, perforation, injuries)
S28_12 25 Congenital hernia repair 1 2
S28_13 26 Neonatal surgery (abdominal wall defect,
colostomy imperforate anus, 1 2
intussusceptions)
S28_14 27 Cleft palate repair 1 2
S28_23 28 Contracture release 1 2
S28_23 29 Skin grafting 1 2
S28_17 30 Open reduction and fixation for fracture 1 2
S28_18 31 Amputation 1 2
S28_19 32 Cataract surgery 1 2
S28_20 33 Club foot repair (casting or open club foot
1 2
release)
S28_21 34 Drainage of osteomyelitis-septic arthritis 1 2
2102 Please tell me if the following surgical A) AVAILABLE B) FUNCTIONING
equipment and supplies are available and
functional in this facility today. NOT DON'T
REPORTED
ASK TO SEE THE ITEMS OBSERVED NOT SEEN AVAILABLE YES NO KNOW
100
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
E23 05 Retractor 3
1→B 2→B 06 1 2 8
E26 08 Tourniquet 3
1→B 2→B 09 1 2 8
Q2104
E29 11 Oropharyngeal airway- adult 3
1→B 2→B 12 1 2 8
101
2. Core instrument
E29 23 Stylet 3
1→B 2→B 24 1 2 8
Q2105
M84 07 Thiopental (powder) 1 2 3 4 5
M85 08 Suxamethonium bromide (powder) 1 2 3 4 5
M86 09 Atropine (injection) 1 2 3 4 5
M25 10 Diazepam (injection) 1 2 3 4 5
102
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
BLOOD TRANSFUSION
S27 2200 Does this facility offer blood transfusion
services? YES ............................................................. 1
NO ............................................................. 2 3000
103
2. Core instrument
ASK TO BE SHOWN THE LOCATION IN THE FACILITY WHERE BLOOD IS COLLECTED, PROCESSED, TESTED, STORED, OR
HANDLED PRIOR TO TRANSFUSION. FIND THE PERSON MOST KNOWLEDGEABLE ABOUT BLOOD TRANSFUSION
SERVICES IN THE FACILITY. INTRODUCE YOURSELF, EXPLAIN THE PURPOSE OF THE SURVEY AND ASK THE
FOLLOWING QUESTIONS.
M66 2201 Have there been any interruptions in blood
availability during the past 3 months? YES ............................................................. 1
NO ............................................................. 2
M67 2202 Does this facility obtain blood from a national
or regional blood centre? YES ............................................................. 1
NO ............................................................. 2
M67 2203 Does this facility obtain ANY blood from
sources other than the national or regional YES ............................................................. 1
blood centre? NO ............................................................. 2
M67 2204 Does any place in this facility do blood
screening for infectious diseases prior to YES ............................................................. 1
transfusion? NO ............................................................. 2 2206
104
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
105
2. Core instrument
SECTION 6: DIAGNOSTICS
3000 Does this facility conduct any diagnostic
testing including any rapid diagnostic testing? YES ..........................................................1
NO ...........................................................2 4000
ASK TO BE SHOWN THE MAIN LABORATORY OR LOCATION IN THE FACILITY WHERE MOST TESTING IS DONE TO
START DATA COLLECTION. INTRODUCE YOURSELF AND EXPLAIN THE PURPOSE OF THE SURVEY, THEN ASK THE
FOLLOWING QUESTIONS.
I would like to know if the following diagnostic tests and associated equipment are available today in this facility.
3100 Does this facility offer any of the following
tests on-site? YES (ONSITE) NO
D9 02 Rapid syphilis testing 1 2
D6 03 HIV rapid testing 1 2
D11 04 Urine rapid tests for pregnancy 1 2
D4 05 Urine protein dipstick testing 1 2
D5 06 Urine glucose dipstick testing 1 2
D20 07 Urine ketone dipstick testing 1 2
D7 08 Dry Blood Spot (DBS) collection for HIV viral
1 2
load or EID
3101 I would like to know if the following items for OBSERVED AVAILABLE NOT OBSERVED
rapid diagnostic testing are available or not
available today. REPORTED
CHECK TO SEE IF AT LEAST ONE OF EACH RDT IS VALID AVAILABLE NOT
AT LEAST ONE AVAILABLE BUT NOT AVAILABLE NEVER
(NOT EXPIRED) VALID NON VALID SEEN TODAY AVAILABLE
106
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
D3 01 Light microscope
D10
D35 3
D8 1→B 2→B 1 2 8
02
D31
D32
D33
03 Refrigerator 3
1→B 2→B 1 2 8
04
D2 04 Glucometer 3
1→B 2→B 1 2 8
05
D2 05 Glucometer test strips (with valid expiration 3
1→B 2→B 1 2 8
date) 06
D1 06 Colorimeter or haemoglobinometer 3
1→B 2→B 1 2 8
07
D1 07 HemoCue 3
1→B 2→B 1 2 8
08
D3 08 Wright-Giemsa stain or other acceptable 3
D35 malaria parasite stain (e.g. Field Stain A and 1→B 2→B 09 1 2 8
B)
D6 09 ELISA washer 3
1→B 2→B 1 2 8
D23 10
D6 10 ELISA reader 3
1→B 2→B 1 2 8
D23 11
107
2. Core instrument
D6 11 Incubator 3
1→B 2→B 1 2 8
D23 12
D6 12 Specific assay kit- HIV antibody testing by 3
1→B 2→B 1 2 8
D23 ELISA 3202
T59 3202 Does this facility have an accredited/certified
D35 microscopist? YES ..........................................................1
NO ...........................................................2
3300 CHECK Q1800:
TB SERVICES OFFERED
TB SERVICES NOT OFFERED
Q3400
D8 3301 Does this facility do Ziehl-Neelsen testing for
TB (AFB) onsite or offsite? YES, ONSITE ............................................1
YES, OFFSITE ...........................................2 3303
NO ...........................................................3 3303
108
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
109
2. Core instrument
Q3600
3502 Please tell me if the following equipment
items and reagents for blood typing and cross A) AVAILABLE B) FUNCTIONING
match are available and functional today.
REPORTED NOT DON'T
ASK TO SEE THE ITEMS OBSERVED YES NO
NOT SEEN AVAILABLE KNOW
D21 01 Centrifuge 3
1→B 2→B 1 2 8
D22 02
D22 02 37° C incubator 3
1→B 2→B 1 2 8
03
D22 03 Grouping sera 3
1→B 2→B 1 2 8
3600
3600 CHECK Q007:
IF HOSPITAL: IF NOT HOSPITAL:
Q4000
3601 Does this facility conduct the following tests DON’T
CONDUCT THE
onsite or offsite?
YES, ONSITE YES, OFFSITE TEST
D24 01 Serum electrolyte testing 1 2 3
D32 02 Urine microscopy testing 1 2 3
D29 03 Syphilis serology testing 1 2 3
D31 04 Gram stain testing 1 2 3
D33 05 CSF/ body fluid counts 1 2 3
D30 06 Cryptococcal antigen testing 1 2 3
D17 07 Molecular biological technique for HIV viral
1 2 3
load or HIV early-infant diagnosis (PCR)
3602 Please tell me if the following equipment
items and reagents are available and A) AVAILABLE B) FUNCTIONING
functional today:
REPORTED NOT DON'T
ASK TO SEE THE ITEMS OBSERVED YES NO
NOT SEEN AVAILABLE KNOW
110
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
111
2. Core instrument
M6 07 Ciprofloxacin cap/tab 1 2 3 4 5
4002 Are any of the following medicines for the OBSERVED NOT OBSERVED
management of non-communicable diseases AVAILABLE
available in the facility today? AT LEAST AVAILABLE NON REPORTED NOT NEVER
ONE VALID VALID AVAILABLE AVAILABLE AVAILABLE
CHECK TO SEE IF AT LEAST ONE OF EACH MEDICINE IS BUT NOT SEEN TODAY
VALID (NOT EXPIRED)
M50 01 Metformin cap/tab 1 2 3 4 5
M51 02 Insulin regular injection 1 2 3 4 5
M52 03 Glucose 50% injection 1 2 3 4 5
M53 04 ACE inhibitor (e.g. enalapril, lisinopril, 1 2 3 4 5
ramipril, perindopril)
M54 05 Thiazide (e.g. hydrochlorothiazide) 1 2 3 4 5
M55 06 Beta blocker (e.g.bisoprolol, metoprolol, 1 2 3 4 5
carvedilol, atenolol)
M56 07 Calcium channel blocker (e.g. amlodipine) 1 2 3 4 5
M57 08 Aspirin cap/tab 1 2 3 4 5
M59 09 Beclomethasone inhaler 1 2 3 4 5
M60 10 Prednisolone cap/tab 1 2 3 4 5
112
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
113
2. Core instrument
114
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
4007
4011
115
2. Core instrument
4011 For each of the following items, please check STOCK- NO STOCK- NOT PRODUCT FACILITY
OUT IN OUT IN PAST INDICATED NOT RECORD NOT
in the facility records if there has been a THE 3 MONTHS OFFERED AVAILABLE
stock-out in the past 3 months: PAST 3
MONTH
S
M81 01 ACT 1 2 3 4 5
M37
116
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
M41 01 Ethambutol 1 2 3 4 5
M41 02 Isoniazid 1 2 3 4 5
M41 03 Pyrazinamide 1 2 3 4 5
M41 04 Rifampicin 1 2 3 4 5
M41 05 Isoniazid + Rifampicin (2FDC) 1 2 3 4 5
M41 06 Isoniazid + Ethambutol (EH) (2FDC) 1 2 3 4 5
M41 07 Isoniazid + Rifampicin + Pyrazinamide (RHZ) 1 2 3 4 5
(3FDC)
M41 08 Isoniazid + Rifampicin + Ethambutol (RHE) 1 2 3 4 5
(3FDC)
M41 09 Isoniazid + Rifampicin + Pyrazinamide + 1 2 3 4 5
Ethambutol (4FDC)
10 Streptomycin injectable 1 2 3 4 5
4018 Does this facility stock any antiretroviral
medicines? YES ............................................................ 1
NO ............................................................. 2 4020
4019 Are any of the following ARVs available today OBSERVED NOT OBSERVED
in this facility? AVAILABLE
CHECK TO SEE IF AT LEAST ONE OF EACH MEDICINE IS AT LEAST ONE AVAILABLE REPORTED NOT NEVER
VALID NON VALID AVAILABLE AVAILABLE AVAILABLE
VALID (NOT EXPIRED)
BUT NOT SEEN TODAY
117
2. Core instrument
118
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
04 Saquinavir (SQV) 1 2 3 4 5
05 Ritonavir (RTV) 1 2 3 4 5
06 Atazanavir (ATV) 1 2 3 4 5
07 Fosamprenavir (FPV) 1 2 3 4 5
08 Tipranavir (TPV) 1 2 3 4 5
09 Darunavir (DRV) 1 2 3 4 5
4022 Are any of the following other medicines and OBSERVED NOT OBSERVED
commodities available in the facility today? AVAILABLE
CHECK TO SEE IF AT LEAST ONE OF EACH AT LEAST ONE AVAILABLE REPORTED NOT NEVER
VALID NON VALID AVAILABLE AVAILABLE AVAILABLE
MEDICINE/COMMODITY IS VALID (NOT EXPIRED)
BUT NOT SEEN TODAY
119
2. Core instrument
120
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
SUPPLY CHAIN
4100 Who is the principal person responsible for
managing the ordering of medical supplies at NURSE ....................................................... 1
this facility? CLINICAL OFFICER ..................................... 2
PHARMACY TECHNICIAN .......................... 3
PHARMACY ASSISTANT ............................. 4
PHARMACIST............................................. 5
MEDICAL ASSISTANT ................................. 6
OTHER __________________________ 96
(SPECIFY)
4101 Which of the following mechanisms is used to YES NO DON’T
determine this facility’s resupply quantities? KNOW
ASK FOR EACH OF THE BELOW
01 The facility itself (pull distribution system) 1 2 3
02 A higher level facility (push distribution 1 2 3
system)
03 Other ________________________ 1 2 3
(SPECIFY)
4102 How are the facility’s resupply quantities
determined? FORMULA (ANY CALCULATION) ................ 1
DON’T KNOW ............................................ 2
OTHER MEANS .......................................... 3
4103 What is the main source of your routine
pharmaceutical commodity supplies? By this I NATIONAL MEDICAL STORES .................... 1
mean who is the direct supplier to your JOINT MEDICAL STORES ............................ 2
facility? NGO/DONORS........................................... 3
PRIVATE SOURCES .................................... 4
OTHER __________________________ 96
(SPECIFY)
4104 How are your pharmaceutical commodity
supplies from the main supplier of your SUPPLIER DELIVERS TO FACILITY............... 1
routine pharmaceuticals delivered to this FACILITY MUST ARRANGE DELIVERY TO
facility? FACILITY .................................................... 2
OTHER __________________________ 96
(SPECIFY)
121
2. Core instrument
122
Service Availability and Readiness Assessment (SARA) | Reference Manual, Version 2.2
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
_____________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
SUPERVISOR'S OBSERVATIONS:
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
123